Accelerate Diagnostics Inc

NASDAQ:AXDX   3:59:50 PM EDT
4.93
+0.16 (+3.35%)
Earnings Announcements

Accelerate Diagnostics Reports Q3 Loss Per Share Of $0.15

Published: 11/09/2021 22:42 GMT
Accelerate Diagnostics Inc (AXDX) - Accelerate Diagnostics Reports Third Quarter 2021 Financial Results.
Q3 Loss per Share $0.15.
Q3 Sales Fell 13 Percent to $3.1 Million.
Q3 Earnings per Share View $-0.33, Revenue View $3.9 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $3.75 Million
Adjusted EPS is expected to be -$0.25

Next Quarter Revenue Guidance is expected to be $4.25 Million
Next Quarter EPS Guidance is expected to be -$0.30

More details on our Analysts Page.